Rahul Sarugaser

Stock Analyst at Raymond James

(0.03)
# 4,364
Out of 4,784 analysts
10
Total ratings
12.5%
Success rate
-26.63%
Average return

Stocks Rated by Rahul Sarugaser

Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $0.60
Upside: +400.00%
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $2.32
Upside: +331.03%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $100
Current: $6.12
Upside: +1,533.99%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $6.05
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11$2.5
Current: $0.63
Upside: +299.23%